Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatitis: an international problem (author's transl)].

F Deinhardt

    MMW, Munchener Medizinische Wochenschrift
    |August 27, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prevalence of human T-cell lymphotropic virus infections in Germany.

    Journal of medical virology·1994
    Same author

    [A new variant of the simian T-lymphotropic retrovirus type I (STLV-IF) in the Sukhumi colony of hamadryas baboons].

    Voprosy virusologii·1993
    Same author

    Production of human cloned antibodies specific for hepatitis D virus-encoded small and large protein.

    Journal of hepatology·1993
    Same author

    Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.

    Vaccine·1993
    Same author

    The immune response to different doses of inactivated hepatitis A vaccine.

    Journal of hepatology·1993
    Same author

    The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.

    Proceedings of the National Academy of Sciences of the United States of America·1992
    Same journal

    [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].

    MMW, Munchener medizinische Wochenschrift·1984
    Same journal

    [Retroperitoneal ganglioneuroma].

    MMW, Munchener medizinische Wochenschrift·1984
    Same journal

    [Is intravenous oxygen therapy defensible? Reflections on 2 cases with severe side effects of such treatment].

    MMW, Munchener medizinische Wochenschrift·1984
    Same journal

    [The oncologic emergency. Surgical therapy of ascites, including tumor ascites].

    MMW, Munchener medizinische Wochenschrift·1984
    Same journal

    [Outside methods. Cytoplasmic therapy of malignant tumors with macromolecular organ extracts].

    MMW, Munchener medizinische Wochenschrift·1984
    Same journal

    [Family of the cancer patient].

    MMW, Munchener medizinische Wochenschrift·1984
    See all related articles

    Hepatitis A, B, and "non A-non B" viral hepatitis have different transmission routes and varying protection from immune serum globulin. Vaccines for hepatitis A and "non A-non B" are unavailable, while hepatitis B vaccine is experimental.

    Area of Science:

    • Virology
    • Immunology
    • Public Health

    Context:

    • Three primary types of viral hepatitis are currently recognized: hepatitis A, hepatitis B, and "non A-non B" hepatitis.
    • Hepatitis A transmission is predominantly fecal-oral, whereas hepatitis B and "non A-non B" hepatitis spread through direct inoculation or close contact.
    • Immune serum globulin offers protection against hepatitis A, but limited efficacy against hepatitis B and "non A-non B" forms.

    Purpose:

    • To differentiate the transmission routes and protective measures for various viral hepatitis types.
    • To highlight the limitations of current immune globulin therapies for hepatitis B and "non A-non B" hepatitis.
    • To identify the developmental status of vaccines for active immunization against hepatitis A, B, and "non A-non B" hepatitis.

    Summary:

    Related Experiment Videos

    • Hepatitis A is primarily transmitted via the anal-oral route, while hepatitis B and "non A-non B" hepatitis are mainly transmitted through direct inoculation or close physical contact.
    • Normal human immune serum globulin effectively protects against hepatitis A but provides limited protection against hepatitis B and "non A-non B" hepatitis.
    • Special immune serum globulin offers better protection but is scarce and recommended only for direct inoculation exposure. Vaccines for hepatitis A and "non A-non B" hepatitis are not yet developed, and hepatitis B vaccination is in the experimental phase.

    Impact:

    • Informs public health strategies for hepatitis prevention and control.
    • Guides clinical decisions regarding immunoglobulin use for post-exposure prophylaxis.
    • Highlights the need for further research and development of effective vaccines for all hepatitis types.